The results were seen by Wall Street analysts as “direct proof-of-concept” that sac-TMT, a drug Merck views as a “cornerstone ...

Scientists at @HopkinsMedicine say they found a class of inhibitors that may lead to better, more effective treatments for ...

AstraZeneca and Gilead have won approval for treatments of an advanced form of the disease.

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune ...

Merck & Co Inc. MRK on Wednesday released topline data from the Phase 3 KEYNOTE‑C93 trial of Keytruda (pembrolizumab). Phase ...

A new antibody‑drug conjugate nearly doubles survival and extends overall survival in advanced triple‑negative breast cancer, offering a more precise first‑line.

Merck stock popped Wednesday on the back of positive test results for a new treatment combo in a common form of lung cancer.

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...

The optimal timing of surgery in patients with resectable advanced ovarian cancer remains controversial. Should these patients receive the standard radical surgery followed by chemotherapy, or could ...

Chemotherapy is one of the most commonly used treatments for cancer, but it can cause side effects. Alternatives include surgery, targeted therapy, and laser therapy. More than 100 types of cancer ...

Immunotherapy plus radiation might provide a chemotherapy-free option for patients with locally advanced, mismatch repair-deficient (MMR-D) and microsatellite instability-high (MSI-H) endometrial ...